Table 2 Susceptibilities of MDR M. tuberculosis isolates of 2009 to fluoroquinolonesa
MIC (mg/L) | Levofloxacin | Moxifloxacin | Sparfloxacin | Gemifloxacin | Gatifloxacin | |||||
|---|---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | No. | % | |
≤0.125 |  |  |  |  |  |  | 2 | 3.8 | 1 | 1.9 |
≤0.25 | 7 | 13.4 | 5 | 9.6 | 14 | 26.9 | 7 | 13.5 | 8 | 15.4 |
0.50 | 10 | 19.2 | 18 | 34.6 | 9 | 17.3 | 14 | 26.9 | 15 | 28.8 |
1Â mg/L | 15 | 28.8 | 15 | 28.8 | 10 | 19.2 | 9 | 17.3 | 7 | 13.5 |
2.00 | 8 | 15.4 | 9 | 17.3 | 8 | 15.4 | 14 | 26.9 | 12 | 23.1 |
4.00 | 8 | 15.4 | 3 | 5.8 | 7 | 13.5 | 6 | 11.5 | 7 | 13.5 |
8.00 | 4 | 7.7 | 2 | 3.8 | 3 | 5.8 | Â | Â | 2 | 3.8 |
16.00 | Â | Â | Â | Â | 1 | 1.9 | Â | Â | Â | Â |
MIC ≥ 2 mg/L | 20 | 38.5 | 14 | 26.9 | 19 | 36.5 | 20 | 38.4 | 21 | 40.4 |
MIC50b | 1.0 | Â | 1.0 | Â | 1.0 | Â | 1.0 | Â | 1.0 | Â |